Global Recombinant Antibody Market Research Report 2021-2025
Recombinant antibodies are antibody fragments produced by using recombinant antibody coding genes. In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Recombinant Antibody Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
In this report, the global Recombinant Antibody market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Recombinant Antibody basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
SinoBiological
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Recombinant Antibody for each application, including-
Hospital
Scientific Research
In this report, the global Recombinant Antibody market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.
The report firstly introduced the Recombinant Antibody basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
The major players profiled in this report include:
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
SinoBiological
The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Recombinant Antibody for each application, including-
Hospital
Scientific Research
PART I RECOMBINANT ANTIBODY INDUSTRY OVERVIEW
CHAPTER ONE RECOMBINANT ANTIBODY INDUSTRY OVERVIEW
1.1 Recombinant Antibody Definition
1.2 Recombinant Antibody Classification Analysis
1.2.1 Recombinant Antibody Main Classification Analysis
1.2.2 Recombinant Antibody Main Classification Share Analysis
1.3 Recombinant Antibody Application Analysis
1.3.1 Recombinant Antibody Main Application Analysis
1.3.2 Recombinant Antibody Main Application Share Analysis
1.4 Recombinant Antibody Industry Chain Structure Analysis
1.5 Recombinant Antibody Industry Development Overview
1.5.1 Recombinant Antibody Product History Development Overview
1.5.1 Recombinant Antibody Product Market Development Overview
1.6 Recombinant Antibody Global Market Comparison Analysis
1.6.1 Recombinant Antibody Global Import Market Analysis
1.6.2 Recombinant Antibody Global Export Market Analysis
1.6.3 Recombinant Antibody Global Main Region Market Analysis
1.6.4 Recombinant Antibody Global Market Comparison Analysis
1.6.5 Recombinant Antibody Global Market Development Trend Analysis
CHAPTER TWO RECOMBINANT ANTIBODY UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Recombinant Antibody Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA RECOMBINANT ANTIBODY INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA RECOMBINANT ANTIBODY MARKET ANALYSIS
3.1 Asia Recombinant Antibody Product Development History
3.2 Asia Recombinant Antibody Competitive Landscape Analysis
3.3 Asia Recombinant Antibody Market Development Trend
CHAPTER FOUR 2016-2021 ASIA RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Recombinant Antibody Production Overview
4.2 2016-2021 Recombinant Antibody Production Market Share Analysis
4.3 2016-2021 Recombinant Antibody Demand Overview
4.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
4.5 2016-2021 Recombinant Antibody Import Export Consumption
4.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Recombinant Antibody Production Overview
6.2 2021-2025 Recombinant Antibody Production Market Share Analysis
6.3 2021-2025 Recombinant Antibody Demand Overview
6.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
6.5 2021-2025 Recombinant Antibody Import Export Consumption
6.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART III NORTH AMERICAN RECOMBINANT ANTIBODY INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN RECOMBINANT ANTIBODY MARKET ANALYSIS
7.1 North American Recombinant Antibody Product Development History
7.2 North American Recombinant Antibody Competitive Landscape Analysis
7.3 North American Recombinant Antibody Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Recombinant Antibody Production Overview
8.2 2016-2021 Recombinant Antibody Production Market Share Analysis
8.3 2016-2021 Recombinant Antibody Demand Overview
8.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
8.5 2016-2021 Recombinant Antibody Import Export Consumption
8.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Recombinant Antibody Production Overview
10.2 2021-2025 Recombinant Antibody Production Market Share Analysis
10.3 2021-2025 Recombinant Antibody Demand Overview
10.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
10.5 2021-2025 Recombinant Antibody Import Export Consumption
10.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART IV EUROPE RECOMBINANT ANTIBODY INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE RECOMBINANT ANTIBODY MARKET ANALYSIS
11.1 Europe Recombinant Antibody Product Development History
11.2 Europe Recombinant Antibody Competitive Landscape Analysis
11.3 Europe Recombinant Antibody Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Recombinant Antibody Production Overview
12.2 2016-2021 Recombinant Antibody Production Market Share Analysis
12.3 2016-2021 Recombinant Antibody Demand Overview
12.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
12.5 2016-2021 Recombinant Antibody Import Export Consumption
12.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Recombinant Antibody Production Overview
14.2 2021-2025 Recombinant Antibody Production Market Share Analysis
14.3 2021-2025 Recombinant Antibody Demand Overview
14.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
14.5 2021-2025 Recombinant Antibody Import Export Consumption
14.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART V RECOMBINANT ANTIBODY MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN RECOMBINANT ANTIBODY MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Recombinant Antibody Marketing Channels Status
15.2 Recombinant Antibody Marketing Channels Characteristic
15.3 Recombinant Antibody Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN RECOMBINANT ANTIBODY NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Recombinant Antibody Market Analysis
17.2 Recombinant Antibody Project SWOT Analysis
17.3 Recombinant Antibody New Project Investment Feasibility Analysis
PART VI GLOBAL RECOMBINANT ANTIBODY INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Recombinant Antibody Production Overview
18.2 2016-2021 Recombinant Antibody Production Market Share Analysis
18.3 2016-2021 Recombinant Antibody Demand Overview
18.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
18.5 2016-2021 Recombinant Antibody Import Export Consumption
18.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Recombinant Antibody Production Overview
19.2 2021-2025 Recombinant Antibody Production Market Share Analysis
19.3 2021-2025 Recombinant Antibody Demand Overview
19.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
19.5 2021-2025 Recombinant Antibody Import Export Consumption
19.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL RECOMBINANT ANTIBODY INDUSTRY RESEARCH CONCLUSIONS
CHAPTER ONE RECOMBINANT ANTIBODY INDUSTRY OVERVIEW
1.1 Recombinant Antibody Definition
1.2 Recombinant Antibody Classification Analysis
1.2.1 Recombinant Antibody Main Classification Analysis
1.2.2 Recombinant Antibody Main Classification Share Analysis
1.3 Recombinant Antibody Application Analysis
1.3.1 Recombinant Antibody Main Application Analysis
1.3.2 Recombinant Antibody Main Application Share Analysis
1.4 Recombinant Antibody Industry Chain Structure Analysis
1.5 Recombinant Antibody Industry Development Overview
1.5.1 Recombinant Antibody Product History Development Overview
1.5.1 Recombinant Antibody Product Market Development Overview
1.6 Recombinant Antibody Global Market Comparison Analysis
1.6.1 Recombinant Antibody Global Import Market Analysis
1.6.2 Recombinant Antibody Global Export Market Analysis
1.6.3 Recombinant Antibody Global Main Region Market Analysis
1.6.4 Recombinant Antibody Global Market Comparison Analysis
1.6.5 Recombinant Antibody Global Market Development Trend Analysis
CHAPTER TWO RECOMBINANT ANTIBODY UP AND DOWN STREAM INDUSTRY ANALYSIS
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of Recombinant Antibody Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
PART II ASIA RECOMBINANT ANTIBODY INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER THREE ASIA RECOMBINANT ANTIBODY MARKET ANALYSIS
3.1 Asia Recombinant Antibody Product Development History
3.2 Asia Recombinant Antibody Competitive Landscape Analysis
3.3 Asia Recombinant Antibody Market Development Trend
CHAPTER FOUR 2016-2021 ASIA RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
4.1 2016-2021 Recombinant Antibody Production Overview
4.2 2016-2021 Recombinant Antibody Production Market Share Analysis
4.3 2016-2021 Recombinant Antibody Demand Overview
4.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
4.5 2016-2021 Recombinant Antibody Import Export Consumption
4.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER FIVE ASIA RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
CHAPTER SIX ASIA RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
6.1 2021-2025 Recombinant Antibody Production Overview
6.2 2021-2025 Recombinant Antibody Production Market Share Analysis
6.3 2021-2025 Recombinant Antibody Demand Overview
6.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
6.5 2021-2025 Recombinant Antibody Import Export Consumption
6.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART III NORTH AMERICAN RECOMBINANT ANTIBODY INDUSTRY (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER SEVEN NORTH AMERICAN RECOMBINANT ANTIBODY MARKET ANALYSIS
7.1 North American Recombinant Antibody Product Development History
7.2 North American Recombinant Antibody Competitive Landscape Analysis
7.3 North American Recombinant Antibody Market Development Trend
CHAPTER EIGHT 2016-2021 NORTH AMERICAN RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
8.1 2016-2021 Recombinant Antibody Production Overview
8.2 2016-2021 Recombinant Antibody Production Market Share Analysis
8.3 2016-2021 Recombinant Antibody Demand Overview
8.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
8.5 2016-2021 Recombinant Antibody Import Export Consumption
8.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER NINE NORTH AMERICAN RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
CHAPTER TEN NORTH AMERICAN RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
10.1 2021-2025 Recombinant Antibody Production Overview
10.2 2021-2025 Recombinant Antibody Production Market Share Analysis
10.3 2021-2025 Recombinant Antibody Demand Overview
10.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
10.5 2021-2025 Recombinant Antibody Import Export Consumption
10.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART IV EUROPE RECOMBINANT ANTIBODY INDUSTRY ANALYSIS (THE REPORT COMPANY INCLUDING THE BELOW LISTED BUT NOT ALL)
CHAPTER ELEVEN EUROPE RECOMBINANT ANTIBODY MARKET ANALYSIS
11.1 Europe Recombinant Antibody Product Development History
11.2 Europe Recombinant Antibody Competitive Landscape Analysis
11.3 Europe Recombinant Antibody Market Development Trend
CHAPTER TWELVE 2016-2021 EUROPE RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
12.1 2016-2021 Recombinant Antibody Production Overview
12.2 2016-2021 Recombinant Antibody Production Market Share Analysis
12.3 2016-2021 Recombinant Antibody Demand Overview
12.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
12.5 2016-2021 Recombinant Antibody Import Export Consumption
12.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER THIRTEEN EUROPE RECOMBINANT ANTIBODY KEY MANUFACTURERS ANALYSIS
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
CHAPTER FOURTEEN EUROPE RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
14.1 2021-2025 Recombinant Antibody Production Overview
14.2 2021-2025 Recombinant Antibody Production Market Share Analysis
14.3 2021-2025 Recombinant Antibody Demand Overview
14.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
14.5 2021-2025 Recombinant Antibody Import Export Consumption
14.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
PART V RECOMBINANT ANTIBODY MARKETING CHANNELS AND INVESTMENT FEASIBILITY
CHAPTER FIFTEEN RECOMBINANT ANTIBODY MARKETING CHANNELS DEVELOPMENT PROPOSALS ANALYSIS
15.1 Recombinant Antibody Marketing Channels Status
15.2 Recombinant Antibody Marketing Channels Characteristic
15.3 Recombinant Antibody Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
CHAPTER SIXTEEN DEVELOPMENT ENVIRONMENTAL ANALYSIS
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
CHAPTER SEVENTEEN RECOMBINANT ANTIBODY NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS
17.1 Recombinant Antibody Market Analysis
17.2 Recombinant Antibody Project SWOT Analysis
17.3 Recombinant Antibody New Project Investment Feasibility Analysis
PART VI GLOBAL RECOMBINANT ANTIBODY INDUSTRY CONCLUSIONS
CHAPTER EIGHTEEN 2016-2021 GLOBAL RECOMBINANT ANTIBODY PRODUCTIONS SUPPLY SALES DEMAND MARKET STATUS AND FORECAST
18.1 2016-2021 Recombinant Antibody Production Overview
18.2 2016-2021 Recombinant Antibody Production Market Share Analysis
18.3 2016-2021 Recombinant Antibody Demand Overview
18.4 2016-2021 Recombinant Antibody Supply Demand and Shortage
18.5 2016-2021 Recombinant Antibody Import Export Consumption
18.6 2016-2021 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER NINETEEN GLOBAL RECOMBINANT ANTIBODY INDUSTRY DEVELOPMENT TREND
19.1 2021-2025 Recombinant Antibody Production Overview
19.2 2021-2025 Recombinant Antibody Production Market Share Analysis
19.3 2021-2025 Recombinant Antibody Demand Overview
19.4 2021-2025 Recombinant Antibody Supply Demand and Shortage
19.5 2021-2025 Recombinant Antibody Import Export Consumption
19.6 2021-2025 Recombinant Antibody Cost Price Production Value Gross Margin
CHAPTER TWENTY GLOBAL RECOMBINANT ANTIBODY INDUSTRY RESEARCH CONCLUSIONS
